AI MARKET SCANNING

Rigel Pharmaceuticals Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +6.50%
MAX GAP RECORD +23.49%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $RIGL
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE)
+9.77%
May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE)
+2.17%
Mar 03, 2026 Earnings Release 2026-03-03 (AFTER CLOSE)
-8.30%
Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE)
+22.87%
Aug 05, 2025 Earnings Release 2025-08-05 (AFTER CLOSE)
+12.13%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
+23.49%
Mar 04, 2025 Earnings Release 2025-03-04 (AFTER CLOSE)
-8.74%
Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE)
+7.84%

VOLATILITY & GAP BIAS

AVG GAP MOVE 9.9%
Bullish Gaps (11)
Bearish Gaps (4)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $RIGL

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1131m +1.52%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗